Klin Farmakol Farm. 2018;32(3):38-42 | DOI: 10.36290/far.2018.021

The problems of alopecia in young women

Anna Hudáková1, Ľudmila Majerníková1, Gabriela Kuriplachová1, Viera Sabolová2
1 Prešovská univerzita v Prešove, Fakulta zdravotníckych odborov, Katedra ošetrovateľstva
2 Dentálna klinika, Humenné

The article is providing a complete owerview on the issues and treatment of alopecia in young women. On the basis of detailedanalysis of the case we have found that the disease affects on teraphy in women. Irreplaceable role in the successful treatment ofalopecia is not only a wide range of therapeutic procedures, as well as access to patient medical, psychological care and adequatesupport from relatives and close friends.

Keywords: alopecia, examinations, impact of disease, therapy

Published: November 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hudáková A, Majerníková Ľ, Kuriplachová G, Sabolová V. The problems of alopecia in young women. Klin Farmakol Farm. 2018;32(3):38-42. doi: 10.36290/far.2018.021.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Braun-Falco O, Plewig G, Wolff HH. 200. Dermatology and Venerology. Berlin: Springer Verlag 2000: 1118-1134. Go to original source...
    2. Rasochová E. Choroby vlasov III - Alopécia areata. Dermatológia pre prax 2011; 5(3): 114-117.
    3. Duchková H, Hašková M. Novinky v léčbě alopecií. Dermatológia pre prax 2015; 9(1): 7-11.
    4. Kožuchová Z. Androgenetická alopécia a súčasné možnosti liečby. Dermatológia pre prax 2015; 9(4): 147-149.
    5. Duchková H, Hašková M. Androgenetická alopecie - diagnostika, diferenciální diagnostika, léčba. Derma 2013; 13(2): 3-10.
    6. Kafková J, Zímová P, Nečas M, Vašků V. Prospective Controlled Study Evaluating Pull Test with Correlation Serum Iron, Ferritin, Tranferin, Vitamin B12, Folic Acid in Patients with Alopecias in The Czech Republic. Hair Ther Transplant 2018; 8(1): 149. DOI: 10.4172/2167-0951.1000149.
    7. Arenberger P. Klinická trichologie: nemoci vlasů a nové trendy v jejich léčbě. Praha: Maxdorf 2002: 192 s.
    8. Bienová M, et al. Androgenetic alopecia and current methods of treatment. Acta Dermatoven APA 2005; 14(1): 5-8.
    9. Rasochová E. Choroby vlasov IV. Difúzne padanie vlasov - anagénne a telogénne deflúvium. Dermatológia pre prax 2011; 5(4): 167-169.
    10. Šimaljaková M. Choroby vlasov II. Dermatológia pre prax 2011; 5(1): 31-34.
    11. Barankin B, DeKoven J. Psychosocial effect of common skin diseases. 2002. [Online]. [cit. 03. 07. 2018]. Dostupné z: https://www.ncbi.nlm.nih.gov/pubmed/12046366.
    12. Knott L. Living with Skin Disease. Patient 2014. [Online]. [cit. 10. 09. 2018]. Dostupné z: http://patient.info/doctor/living-with-skin-disease.
    13. Lad W, Suryawanshi CH, Sinhal A, Landge A, Wagh V, Jadhav N. Androgenic Alopecia: Current Perspectives & Treatments. World Journal of Pharmacy and Pharmaceutical Sciences 2017; 6(3): 641-653.
    14. Poláková K. Spolupráca gynekológa a dermatológa pri užívaní kombinovanej hormonálnej antikoncepcie s antiandrogénovým účinkom. Dermatológia pre prax 2010; 4(3): 113-115.
    15. Turčeková L. Dopad dermatologického ochorenia na sebakoncepciu postihnutého. Dermatológia pre prax 2010; 4(4): 149-151.
    16. Elise A, Olsen MD. Female pattern hair loss. Journal of the American Academy of Dermatology 2001; 45(3): S70-80. Go to original source... Go to PubMed...
    17. Tosti A, Bellavista S, Iorizzo M. Alopecia areata: A long term follow-up study of 191 patients. Journal of the American Academy of Dermatology 2006; 55: 438-441. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.